Theravance (THRX) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts THRX Hot Sheet
Price: $4.06 --0%
Financial Fact:
Research and development: 286K
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Research and development: 286K
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Theravance (NASDAQ: THRX) reported Q2 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $10.7 million versus the consensus estimate of $10.9 million.
For earnings history and earnings-related data on Theravance (THRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Quantum BioPharma gets FDA nod for Lucid-MS Phase 2 MS trial
- Calamp Corp. (CAMP) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
